Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00146445 · ClinicalTrials.gov registry record · Phase 2
Behavioral Intervention Trial for HIV-infected Injection Drug Users
A Phase 2 study of HIV, sponsored by Centers for Disease Control and Prevention.
- Completed
- Registry status
- Phase 2
- Development phase
- 1,000
- Enrollment target
- 5
- Study locations
NCT00146445 is a Phase 2 study of HIV that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 1,000 participants, above the 437-participant average among 303 other HIV trials with a reported enrollment target (129% higher). The trial reports 5 study locations across 4 states.
The verdict
NCT00146445, a Phase 2 study of HIV, has completed, sponsored by Centers for Disease Control and Prevention.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1,000 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this study is to test whether a ten-session behavioral intervention for HIV-infected injection drug users is effective in reducing sex and injection risk behaviors that put others at risk for HIV infection, increasing access to or utilization of HIV primary health care, and increasing adherence to HIV medications.
Conditions Studied
Interventions
- BEHAVIORAL Peer Mentoring Intervention
Study Locations (5)
New York
- New York Academy of Medicine - New York
- Montefiore Medical Center - The Bronx
California
- University of California - San Francisco - San Francisco
Florida
- University of Miami - Miami
Maryland
- Johns Hopkins University - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2001-08 |
| Est. Completion | 2006-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00146445
The ClinicalTrials.gov registry entry for NCT00146445 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 437-participant average among 303 other HIV trials with a reported enrollment target (129% higher). The listed sponsor is Centers for Disease Control and Prevention, which has 139 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 1 intervention - of which Peer Mentoring Intervention is the first listed.
NCT00146445 reports 5 study locations spanning 4 distinct geographic areas - top geographies include New York, California, Florida.
Frequently Asked Questions
What is clinical trial NCT00146445 about?
NCT00146445 is a clinical study titled "Behavioral Intervention Trial for HIV-infected Injection Drug Users". The purpose of this study is to test whether a ten-session behavioral intervention for HIV-infected injection drug users is effective in reducing sex and injection risk behaviors that put others at risk for HIV infection, increasing access to or utilization of HIV primary health care, and increasing...
What is the current status of trial NCT00146445?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 1,000 participants. The study started on 2001-08. Estimated completion is 2006-07.
What conditions does trial NCT00146445 study?
This clinical trial studies the following conditions: HIV.
What interventions are being tested in trial NCT00146445?
The interventions under investigation include: Peer Mentoring Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00146445?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00146445 being conducted?
This trial has 5 study locations across California, Florida, Maryland, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV
RECRUITING · Phase 2
-
Improving Physical Ability and Cellular Senescence Elimination in HIV
RECRUITING · Phase 2
-
Evaluation Of Semaglutide in Adults With Cocaine Use Disorder With and Without HIV
RECRUITING · Phase 2
-
Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 Semaglutide
RECRUITING · Phase 2
-
Neuroactive Steroid to Treat Depressed Mood: A Trial for People With HIV
RECRUITING · Phase 2
-
A Study of VRC07-523LS, PGT121.414.LS, and PGDM1400LS Broadly Neutralizing Monoclonal Antibodies Given Intravenously in Adult Participants Without HIV
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.